Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for anal carcinoma: are there differences between HIV-positive and HIV-negative patients in the era of highly active antiretroviral therapy?

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Radiotherapy and Oncology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.radonc.2010.11.011PMID 21168927
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for invasive anal carcinoma in human immunodeficiency virus-positive patients receiving highly active antiretroviral therapy.

  2010cited by this paper
• Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients.

  2009cited by this paper
• HIV and Anal Cancer Outcomes: A Single Institution's Experience

  2009cited by this paper
• Phase I trial of the human immunodeficiency virus protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer.

  2008cited by this paper
• Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial.

  2008cited by this paper
• HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: a multicentric cohort study of HIV-positive patients receiving highly active antiretroviral therapy.

  2008cited by this paper
• Human immunodeficiency virus-associated squamous cell cancer of the anus: epidemiology and outcomes in the highly active antiretroviral therapy era.

  2008cited by this paper
• Invasive Anal Squamous-Cell Carcinoma in the HIV-Positive Patient: Outcome in the Era of Highly Active Antiretroviral Therapy

  2008cited by this paper
• Anal Carcinomas in HIV-Positive Patients: High-Dose Chemoradiotherapy Is Feasible in the Era of Highly Active Antiretroviral Therapy

  2005cited by this paper
• Interactions Between Antiretrovirals and Antineoplastic Drug Therapy

  2005cited by this paper
• Outcome of HIV-Infected Patients With Invasive Squamous-Cell Carcinoma of the Anal Canal in the Era of Highly Active Antiretroviral Therapy

  2004cited by this paper
• The human immunodeficiency virus (HIV)-1 protease inhibitor saquinavir inhibits proteasome function and causes apoptosis and radiosensitization in non-HIV-associated human cancer cells.

  2002cited by this paper
• HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patients

  2001cited by this paper
• Outcome analysis of HIV-positive patients with anal squamous cell carcinoma

  2001cited by this paper
• Treatment of HIV-associated invasive anal cancer with combined chemoradiation.

  2000cited by this paper
• The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer.

  1999cited by this paper
• Saquinavir enhances the mucosal toxicity of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma

  1998cited by this paper
• Chemotherapy and low-dose radiotherapy in the treatment of HIV-infected patients with carcinoma of the anal canal.

  1997cited by this paper
• Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.

  1997cited by this paper
• Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research.

  1996cited by this paper
• Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study.

  1996cited by this paper
• Tolerance of patients with human immunodeficiency virus and anal carcinoma to treatment with combined chemotherapy and radiation therapy.

  1994cited by this paper
• Squamous-cell carcinoma of the anus in HIV-positive patients

  1994cited by this paper

• Radiation Therapy for Anal Squamous Cell Carcinoma: An ASTRO Clinical Practice Guideline.

  2025cites this paper
• Health Disparities and Anal Cancer.

  2024cites this paper
• Mortalidade em pacientes com câncer de canal anal em um hospital oncológico público do Distrito Federal

  2024cites this paper
• Anal Cancer: The Past, Present and Future

  2023cites this paper
• Prognostic Factors of Long-Term Outcomes after Primary Chemo-Radiotherapy in Non-Metastatic Anal Squamous Cell Carcinoma: An International Bicentric Cohort

  2023cites this paper
• Characteristics and oncological results of epidermoid anal carcinoma: Comparison analysis between immunocompetent and immunosuppressed patients.

  2022cites this paper
• Biomarkers in Anal Cancer: Current Status in Diagnosis, Disease Progression and Therapeutic Strategies

  2022cites this paper
• Anal squamous cell carcinoma: Impact of radiochemotherapy evolution over years and an explorative analysis of MRI prediction of tumor response in a mono-institutional series of 131 patients

  2022cites this paper
• Characteristics and oncological results of epidermoid anal carcinoma: Comparison analysis between immunocompetent and immunosuppressed patients.

  2021cites this paper
• A systematic review and meta-analysis of mortality in anal cancer patients by HIV status.

  2021cites this paper
• Prognostic impact of neutrophilia and lymphopenia on survival in anal cancer treated with definitive concurrent chemoradiotherapy: a retrospective multicenter study

  2021cites this paper
• Anale Dysplasien und Analkarzinom

  2020cites this paper
• Feasibility and Outcome of Routine Use of Concurrent Chemoradiation in HIV-positive Patients With Squamous Cell Anal Cancer

  2020cites this paper
• Disease-Free Survival and Time to Complete Response After Definitive Chemoradiotherapy for Squamous-Cell Carcinoma of the Anus According to HIV Infection.

  2020cites this paper
• Anal dysplasia and anal cancer. English version

  2020cites this paper
• Difference in toxicity between HIV-positive and HIV-negative patients with squamous-cell cancer of the anal canal treated with concomitant radio-chemotherapy.

  2020influential citation
• Staging and Initial Evaluation of Anal Cancer

  2019cites this paper
• The impact of HIV status on staging, treatment and outcomes in locally advanced cervical carcinoma

  2019cites this paper
• A case of esophageal cancer with human immunodeficiency virus infection that progressed rapidly after neoadjuvant chemoradiotherapy

  2019cites this paper
• Management of locally advanced anal canal carcinoma with intensity-modulated radiotherapy and concurrent chemotherapy

  2018cites this paper
• Organ-Specific Toxicities Due to Radiation Therapy in Cancer Patients With or Without HIV Infection: A Systematic Review of the Literature

  2018cites this paper
• Treatment outcomes of patients with localized anal squamous cell carcinoma according to HIV infection: systematic review and meta-analysis.

  2018cites this paper
• HPV-Associated Anal Cancer in the HIV/AIDS Patient.

  2018cites this paper
• Association of HIV Status With Outcomes of Anal Squamous Cell Carcinoma in the Era of Highly Active Antiretroviral Therapy

  2018cites this paper
• Prognostic Value of Pre-treatment F-18 FDG PET Metabolic Metrics in Patients with Locally Advanced Carcinoma of the Anus with and without HIV Infection

  2018cites this paper
• Association of Coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the Management of Cancer of the Colon, Rectum and Anus (2017) – Multidisciplinary Management

  2017cites this paper
• Are there HIV-specific Differences for Anal Cancer Patients Treated with Standard Chemoradiotherapy in the Era of Combined Antiretroviral Therapy?

  2017cites this paper
• Human Immunodeficiency Virus/AIDS, Human Papillomavirus, and Anal Cancer.

  2017cites this paper
• Anal cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SNFCP).

  2017cites this paper
• Nodal stage migration and prognosis in anal cancer: a systematic review, meta-regression, and simulation study.

  2017cites this paper
• Association of Coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the Management of Cancer of the Colon, Rectum and Anus (2017) – Anal Cancer

  2017cites this paper
• Leukocytosis and neutrophilia predicts outcome in anal cancer.

  2017cites this paper
• Comparison of Toxicity and Treatment Outcomes in HIV-positive Versus HIV-negative Patients With Squamous Cell Carcinoma of the Anal Canal

  2017cites this paper
• Effect of CD4 Count on Treatment Toxicity and Tumor Recurrence in Human Immunodeficiency Virus e Positive Patients With Anal Cancer

  2017cites this paper
• HIV/AIDS, HPV and Anal Cancer

  2017cites this paper
• Effect of CD4 Count on Treatment Toxicity and Tumor Recurrence in Human Immunodeficiency Virus-Positive Patients With Anal Cancer.

  2017cites this paper
• Development and validation of a machine learning-based predictive model to improve the prediction of inguinal status of anal cancer patients: A preliminary report

  2016cites this paper
• HPV-induzierte anale Läsionen

  2016cites this paper
• Cost-Effectiveness Study of HPV Vaccination as a Primary Prevention Strategy for Anal Cancer in HIV-Positive Men in Chile.

  2016cites this paper
• HIV Infection and Survival Among Women With Cervical Cancer.

  2016cites this paper
• [HPV-induced anal lesions].

  2015cites this paper
• HPV-induzierte anale Läsionen

  2015cites this paper
• [Recommendations for the management of cancers of the anal canal].

  2015cites this paper
• Anal cancer treatment: current status and future perspectives.

  2015cites this paper
• HIV Infection Is Associated With Poor Outcomes for Patients With Anal Cancer in the Highly Active Antiretroviral Therapy Era

  2015cites this paper
• HIV Status and Acute Hematologic Toxicity Among Patients With Cervix Cancer Undergoing Radical Chemoradiation

  2015cites this paper
• Anal Squamous Cell Carcinoma in African Americans with and without HIV: A Comparative Study

  2015cites this paper
• Therapie des Analkarzinoms

  2014cites this paper
• Case 16-2014

  2014cites this paper
• Anal intraepithelial neoplasia and squamous cell carcinoma in HIV‐infected adults

  2014cites this paper
• Case records of the Massachusetts General Hospital. Case 16-2014. A 46-year-old woman in Botswana with postcoital bleeding.

  2014cites this paper
• Long-term Effects of Chemoradiotherapy for Anal Cancer in Patients With HIV Infection: Oncological Outcomes, Immunological Status, and the Clinical Course of the HIV Disease

  2014cites this paper
• Anal cancer: ESMO–ESSO–ESTRO clinical practice guidelines for diagnosis, treatment and follow-up

  2014cites this paper
• Colorectal and anal cancer in HIV/AIDS patients: a comprehensive review

  2014cites this paper
• Role of brachytherapy in the treatment of cancers of the anal canal

  2014cites this paper
• British HIV Association guidelines for HIV‐associated malignancies 2014

  2014cites this paper
• Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up.

  2014cites this paper
• Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up.

  2014cites this paper
• ANAL CANCER IN HIV-POSITIVE PATIENTS

  2014cites this paper
• Chemoradiotherapy for squamous cell cancer of the anal canal: a systematic review.

  2014cites this paper
• The evolving scenario of non-AIDS-defining cancers: challenges and opportunities of care.

  2014cites this paper
• Predictive Factors for Early and Late Local Toxicities in Anal Cancer Treated by Radiotherapy in Combination With or Without Chemotherapy

  2013cites this paper
• Anal cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2013cites this paper
• Simultane Radiochemotherapie des Analkarzinoms bei Patienten mit HIV-Infektion

  2012cites this paper
• Chemotherapy/chemoradiation in anal cancer: a systematic review.

  2011cites this paper